Joshua A Roth

14PUBLICATIONS
39CO-AUTHORS
Cancer diagnosisGene and molecular therapyNanotoxicology, health and safetyPharmacogenomicsNot-for-profit finance and risk
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 06, 2026
Cost-efficiency modeling of conversion to biosimilar rituximab-based R-CHOP in diffuse large B-cell lymphoma in medicare.

Joshua A Roth, David Kratochvil, Kathryn Perkins

|Dec 03, 2025
Real-world treatment and utilization of venetoclax for incident acute myeloid leukemia in a Medicare population.

Joshua A Roth, Paul G D'Amico, Joseph C Cappelleri

|Feb 26, 2025
Defining a Framework for Sustainable Global Biosimilars Markets Using Findings from a Targeted Literature Review.

Joshua A Roth, Victoria W Dayer, Mireia Jofre-Bonet

|Jun 12, 2024
A descriptive analysis of real-world oncology biosimilar use in Japan.

Joshua A Roth, Makan Rahshenas, Grégoire Nowacki

|May 20, 2024
Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review.

Grace E Fox, Mark Bernauer, Jennifer M Stephens

Pageof 3